Amended Statement of Changes in Beneficial Ownership (4/a)
September 15 2021 - 4:12PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
MUKUNDA RAM |
2. Issuer Name and Ticker or Trading Symbol
India Globalization Capital, Inc.
[
IGC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) CEO |
(Last)
(First)
(Middle)
10224 FALLS ROAD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/15/2021 |
(Street)
POTOMAC, MD 20854
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
5/13/2021 |
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
COMMON STOCK | 5/13/2021 | | A | | 1000000 (1) | A | $0.00 | 3174760 (2) | D | |
COMMON STOCK | 5/13/2021 | | A | | 50000 (1) | A | $0.00 | 777417 | I | BY SPOUSE |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | Represents restricted shares of common stock subject to vesting over three years. |
(2) | This Form 4 is being filed to reflect the correct ownership amount of the Reporting Person. All previous Section 16 filings of the Reporting Person since April 19, 2013 overstated the Reporting Person's ownership by 600,000 shares. Accordingly, the Reporting person owns 3,174,760 shares of Common Stock as opposed to the 3,774,760 shares previously reported on the Form 4. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
MUKUNDA RAM 10224 FALLS ROAD POTOMAC, MD 20854 | X |
| CEO |
|
Signatures
|
/s/ Ram Mukunda | | 9/15/2021 |
**Signature of Reporting Person | Date |
IGC Pharma (AMEX:IGC)
Historical Stock Chart
From Sep 2024 to Oct 2024
IGC Pharma (AMEX:IGC)
Historical Stock Chart
From Oct 2023 to Oct 2024